(Q51058191)

http://europepmc.org/abstract/MED/25182247

27 March 2018

title

Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation. (English)

1 reference

http://europepmc.org/abstract/MED/25182247

27 March 2018

0 references

0 references

0 references

1 reference

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25182247%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Paulus Kirchhof

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25182247%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Mario Talajic

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25182247%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

2

Michael D Ezekowitz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25182247%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

6

Jean-Yves Le Heuzey

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25182247%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

4

A John Camm

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25182247%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

16

Stefan H Hohnloser

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25182247%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

9

Panos E Vardas

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25182247%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

1

Riccardo Cappato

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25182247%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

13

Isabelle Ling Meng

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25182247%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

15

Martin van Eickels

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25182247%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

3

Allan L Klein

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25182247%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

11

Melanie Hemmrich

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25182247%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

12

Vivian Lanius

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25182247%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

14

Peter Wildgoose

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25182247%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

author name string

Chang-Sheng Ma

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25182247%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

X-VeRT Investigators

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25182247%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

publication date

2 September 2014

1 reference

http://europepmc.org/abstract/MED/25182247

27 March 2018

published in

European Heart Journal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25182247%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25182247%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

page(s)

3346-3355

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25182247%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

issue

47

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25182247%20AND%20SRC:MED&resulttype=core&format=json

Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutter

31 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU367

Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU367

2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU367

Dabigatran versus warfarin in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU367

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU367

Apixaban versus warfarin in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU367

Edoxaban versus warfarin in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU367

Outcomes after cardioversion and atrial fibrillation ablation in patients treated with rivaroxaban and warfarin in the ROCKET AF trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU367

Rationale and design of the eXplore the efficacy and safety of once-daily oral riVaroxaban for the prEvention of caRdiovascular events in patients with nonvalvular aTrial fibrillation scheduled for cardioversion trial: A comparison of oral rivaroxab

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU367

Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU367